Biotech Values

[turtlepower]

OGXI is perhaps another example. They had very little cash when they signed the deal with Teva.

What type of deal would be viewed as positive for SNTA? The shares are trading with an EV of about 170 M for a wholly owned program. Would a 50-75 M upfront and 15%+ royalty be viewed as a plus or will shares start trading like OGXI with a smaller EV?